[
  {
    "ts": null,
    "headline": "Truist Lowers Neurocrine Biosciences, Inc.’s (NBIX) PT Following 2026 Outlook Update",
    "summary": "Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is among the 7 Oversold Pharma Stocks to Buy Now. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is one of the most oversold stocks. TheFly reported on February 17 that Truist reduced its price target on NBIX to $140 from $169 and maintained a Buy rating on the stock. The increase came after management’s 2026 projection, and the company’s fourth-quarter results were […]",
    "url": "https://finnhub.io/api/news?id=333c196276972372e33389d00beadef9c6db20854cd12d568ad7d56eae6ce3a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771882084,
      "headline": "Truist Lowers Neurocrine Biosciences, Inc.’s (NBIX) PT Following 2026 Outlook Update",
      "id": 139188090,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is among the 7 Oversold Pharma Stocks to Buy Now. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is one of the most oversold stocks. TheFly reported on February 17 that Truist reduced its price target on NBIX to $140 from $169 and maintained a Buy rating on the stock. The increase came after management’s 2026 projection, and the company’s fourth-quarter results were […]",
      "url": "https://finnhub.io/api/news?id=333c196276972372e33389d00beadef9c6db20854cd12d568ad7d56eae6ce3a0"
    }
  },
  {
    "ts": null,
    "headline": "Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive",
    "summary": "Edwards Lifesciences Corporation (NYSE:EW) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 11, Richard Newitter from Truist Financial reduced the price target on Edwards Lifesciences Corporation (NYSE:EW) from $92 to $89. The analyst reaffirmed his Hold rating on the stock that offers a revised upside potential […]",
    "url": "https://finnhub.io/api/news?id=3ea9ebe20eb88d52de63b846690c118bf0b80490e3377b89601e494db47558e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771879503,
      "headline": "Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive",
      "id": 139188091,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences Corporation (NYSE:EW) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 11, Richard Newitter from Truist Financial reduced the price target on Edwards Lifesciences Corporation (NYSE:EW) from $92 to $89. The analyst reaffirmed his Hold rating on the stock that offers a revised upside potential […]",
      "url": "https://finnhub.io/api/news?id=3ea9ebe20eb88d52de63b846690c118bf0b80490e3377b89601e494db47558e3"
    }
  },
  {
    "ts": null,
    "headline": "Visa (V) Balances Innovation with Market Expectations",
    "summary": "Visa Inc. (NYSE:V) is one of Goldman Sachs’s top growth stock picks. On February 10, Truist Securities analyst Matthew Coad cut the firm’s price target on Visa, Inc. (NYSE:V) to $372 from $374, while keeping a Buy rating on the stock. The target adjustment was part of a broader research update in which Truist revised […]",
    "url": "https://finnhub.io/api/news?id=a4db7279e0359a680c7bd95a88b96ccef3ed7a36d8eff9a86ff7d61f81b1999e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771876158,
      "headline": "Visa (V) Balances Innovation with Market Expectations",
      "id": 139187243,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Visa Inc. (NYSE:V) is one of Goldman Sachs’s top growth stock picks. On February 10, Truist Securities analyst Matthew Coad cut the firm’s price target on Visa, Inc. (NYSE:V) to $372 from $374, while keeping a Buy rating on the stock. The target adjustment was part of a broader research update in which Truist revised […]",
      "url": "https://finnhub.io/api/news?id=a4db7279e0359a680c7bd95a88b96ccef3ed7a36d8eff9a86ff7d61f81b1999e"
    }
  },
  {
    "ts": null,
    "headline": "Mastercard (MA) Strengthens Banking Ties, Maintains Dividends",
    "summary": "Mastercard Incorporated (NYSE:MA) is one of Goldman Sachs’s top growth stock picks. On February 12, Mastercard Incorporated’s (NYSE:MA) open finance technology became the backbone of Truist Financial’s first-ever open banking platform. Truist will use Mastercard’s open finance API network to replace the risky practice of credential-sharing with tokenized, permissioned API connections. The technology acts as […]",
    "url": "https://finnhub.io/api/news?id=de008fc220a73912d86b1afe3ee439e2f6517067cc27a8ba5d9d5b2eb0ddab8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771876156,
      "headline": "Mastercard (MA) Strengthens Banking Ties, Maintains Dividends",
      "id": 139187253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Mastercard Incorporated (NYSE:MA) is one of Goldman Sachs’s top growth stock picks. On February 12, Mastercard Incorporated’s (NYSE:MA) open finance technology became the backbone of Truist Financial’s first-ever open banking platform. Truist will use Mastercard’s open finance API network to replace the risky practice of credential-sharing with tokenized, permissioned API connections. The technology acts as […]",
      "url": "https://finnhub.io/api/news?id=de008fc220a73912d86b1afe3ee439e2f6517067cc27a8ba5d9d5b2eb0ddab8e"
    }
  },
  {
    "ts": null,
    "headline": "Truist Raises Target Price on Etsy (ETSY) to $83, Following Q4 Results",
    "summary": "Etsy Inc. (NASDAQ:ETSY) is one of the 14 Best Consumer Discretionary Stocks to Buy Right Now. Truist, on February 20, raised its target price on Etsy by 3.8% to $83 (from $80) and retained its Buy recommendation. The firm thinks that Etsy, following the release of the company’s Q4 2025 results and Q1 2026 guidance, is […]",
    "url": "https://finnhub.io/api/news?id=41f43476cc1eb25803a55943ccae2dcee34d431917ebc3ef085976434a40a469",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771872384,
      "headline": "Truist Raises Target Price on Etsy (ETSY) to $83, Following Q4 Results",
      "id": 139187410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Etsy Inc. (NASDAQ:ETSY) is one of the 14 Best Consumer Discretionary Stocks to Buy Right Now. Truist, on February 20, raised its target price on Etsy by 3.8% to $83 (from $80) and retained its Buy recommendation. The firm thinks that Etsy, following the release of the company’s Q4 2025 results and Q1 2026 guidance, is […]",
      "url": "https://finnhub.io/api/news?id=41f43476cc1eb25803a55943ccae2dcee34d431917ebc3ef085976434a40a469"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
    "summary": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=58abd29852f1d0017343572242e72cb9542b03aa309715e386a1f6f5a8fc72bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771857179,
      "headline": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
      "id": 139185068,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Alphabet, Nvidia upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=58abd29852f1d0017343572242e72cb9542b03aa309715e386a1f6f5a8fc72bc"
    }
  },
  {
    "ts": null,
    "headline": "How The DaVita (DVA) Investment Story Is Shifting With New Targets And Fair Value Assumptions",
    "summary": "DaVita’s refreshed fair value estimate has shifted from US$147.75 to US$151.71, reflecting a modest 2.7% adjustment in the modelled price target. That move aligns with a series of price target changes from several firms, where higher targets sit alongside research that still flags meaningful risks for you to weigh. As you read on, you will see how these updates fit into the evolving analyst narrative and what to watch if you are tracking DaVita’s story over time. Stay updated as the Fair...",
    "url": "https://finnhub.io/api/news?id=0433909f4e2ab18981af1f92216a50dbcf1e4dd02937adcb17e2784b5428e067",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771852303,
      "headline": "How The DaVita (DVA) Investment Story Is Shifting With New Targets And Fair Value Assumptions",
      "id": 139183812,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "DaVita’s refreshed fair value estimate has shifted from US$147.75 to US$151.71, reflecting a modest 2.7% adjustment in the modelled price target. That move aligns with a series of price target changes from several firms, where higher targets sit alongside research that still flags meaningful risks for you to weigh. As you read on, you will see how these updates fit into the evolving analyst narrative and what to watch if you are tracking DaVita’s story over time. Stay updated as the Fair...",
      "url": "https://finnhub.io/api/news?id=0433909f4e2ab18981af1f92216a50dbcf1e4dd02937adcb17e2784b5428e067"
    }
  },
  {
    "ts": null,
    "headline": "How The Markel Group (MKL) Narrative Is Shifting With New Targets And Buybacks",
    "summary": "Markel Group’s latest analyst update lifts the price target by about US$100, moving fair value from US$2,064.25 to US$2,071.75, a small change that still matters if you are tracking valuation closely. Bullish and cautious voices are reading this shift differently, with some treating it as confirmation of an already supportive view and others seeing it as only a modest tweak. As you read on, you will see how to interpret these moves and keep up with the evolving narrative around Markel...",
    "url": "https://finnhub.io/api/news?id=d1c2ac476f15d4cfc126b2cdc834f38fd29f2ef5bd66513a990b1908d5f92b28",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771812461,
      "headline": "How The Markel Group (MKL) Narrative Is Shifting With New Targets And Buybacks",
      "id": 139180635,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Markel Group’s latest analyst update lifts the price target by about US$100, moving fair value from US$2,064.25 to US$2,071.75, a small change that still matters if you are tracking valuation closely. Bullish and cautious voices are reading this shift differently, with some treating it as confirmation of an already supportive view and others seeing it as only a modest tweak. As you read on, you will see how to interpret these moves and keep up with the evolving narrative around Markel...",
      "url": "https://finnhub.io/api/news?id=d1c2ac476f15d4cfc126b2cdc834f38fd29f2ef5bd66513a990b1908d5f92b28"
    }
  }
]